Did you know that approximately 0.6% of the Canadian population has epilepsy? What you may not know is that epilepsy is NOT a rare disease. There are more than twice as many people living with epilepsy as the number of people with cerebral palsy, muscular dystrophy, mu...

When managing a devastating disease, sometimes a small change can make a big difference. For patients with HIV who are virologically suppressed and stable, that change is on the horizon. Last week, Canada approved GlaxoSmithKline ViiV Healthcare’s long-acting HIV treat...

The rapidly-advancing COVID-19 pandemic has had a wide range of byproducts: cancelled plans, constant uncertainty and, for some, a sudden shift in workplace. As many companies have implemented work-from-home policies to help prevent the spread of the virus, consider th...

The Horizon2020 project SOLUS team aims to begin testing their non-invasive breast imaging system beginning in late 2020. While, mammography can accurately detect breast lesions there a still a large number of false positives, which lead to unnecessary biopsies. The te...

#IAMRESILIENT2020

March is Myeloma Action Month. This year the theme is “I am Resilient.” This theme was inspired by an art installation shown at the International Myeloma Foundation’s 13th Annual Comedy Celebration in October 2019 which featured 100 photographs from IM...

Sunday, March 8th is International Women’s Day (IWD) and this year’s theme is “Each for Equal”, encouraging each of us to do what we can to create a gender equal world. International Day of Women and Girls in Science also took place recently on February 11th. Did you k...

​Rare diseases can be difficult to find and diagnose, let alone treat. While they may have low incidences, rare diseases are not rare: over 7000 have been identified to date and approximately 300 million people worldwide are living with one. 

Here at MEDUCOM, we “showed...

Lunchtime, birthday parties and sleepovers may no longer need to be cause for concern thanks to Palforzia, a recently U.S. FDA-approved “oral immunotherapy” to treat peanut allergy – the first North American-approved food allergy medication.

Millions of Canadians have f...

The physical and mental health benefits of being in the outdoors have long been recognized. Besides simply encouraging people to spend more time outside, researchers are increasingly interested in how to harness these benefits through more deliberate and structured use...

Direct-to-consumer genetic testing company 23andMe announced last month that it had licensed its first in-house developed drug, a biologic, to Spanish drugmaker Almirall SA. The bispecific monoclonal antibody targets the IL-36 cytokine, which is associated with autoimm...